Skip to main content
. 2021 Sep 1;190(2):213–226. doi: 10.1007/s10549-021-06370-w

Fig. 1.

Fig. 1

Fig. 1

ctDNA mutation landscapes of US and Chinese HR+ MBC patients. A Mutation profile of US cohort. B Mutation profile of Chinese cohort. C Prevalence of gene mutation, copy number (CN) gain, and CN loss in US and Chinese cohorts. P value was calculated using one-side Fisher’s exact test